Heart Disease News and Research

Latest Heart Disease News and Research

$Surgeons implant a new investigational neurostimulator in a patient with medically refractory epilepsy$

Surgeons implant a new investigational neurostimulator in a patient with medically refractory epilepsy

Neurosurgeons at Rush University Medical Center are the first in Chicago to implant a new investigational neurostimulator in a patient with medically refractory epilepsy.

5 Aug 2004

New guidelines for water, salt and potassium intake of Americans

Nutrition experts from the Institute of Medicine of the National Academies have released new guidelines for water, salt and potassium intake of Americans.

5 Aug 2004

24-year long asthma study is answering doctors' questions about asthma and its causes

Doctors have concluded that children do not usually outgrow asthma after puberty as was previously assumed. There are also other factors that contribute to the onset of asthma in test subjects, including infection and obesity.

5 Aug 2004

Mefloquine, an anti-malarial drug plays a critical role in movement, vision and memory

Brown University researchers have discovered that mefloquine, an anti-malarial drug, blocks two gap junction proteins, or connexins, in low doses and with very few side effects in the brains of laboratory mice.

5 Aug 2004

25% of young men tested positive for a sexually transmitted infection (STI)

25% of young men attending a new community sexual health clinic, run by Guy’s and St Thomas’ NHS Foundation Trust in the heart of Brixton, have tested positive for a sexually transmitted infection (STI).

5 Aug 2004

Current estimates have cardiovascular disease (CVD) accounting for 17 million deaths annually

Renowned public health specialist, Professor Stephen Leeder, will present the central findings of a report highlighting the disturbing trend towards a growth in cardiovascular disease in developing countries, at a special colloquium to be held at The University of Sydney.

5 Aug 2004

Approval of cholesterol-lowering therapy Lipitor for the prevention of cardiovascular disease

Pfizer has announced that the U.S. Food and Drug Administration has approved its cholesterol-lowering therapy Lipitor® (atorvastatin calcium) for the prevention of cardiovascular disease by reducing heart attack risk in people with normal to mildly elevated cholesterol levels who have other cardiovascular risk factors.

5 Aug 2004

Moderate exercise helps beat fatigue from prostate radiation

Men who get a moderate amount of exercise during radiation for prostate cancer are better able to cope with the fatigue the treatment can cause, researchers from Scotland report in the journal Cancer.

5 Aug 2004

Atherosclerosis at menopause slowed by diet and exercise

Thickening of artery walls accelerates as women enter menopause, but these signs of the progression of atherosclerosis can be slowed by a lower-fat diet and increased physical activity, according to a new study in the Aug. 4, 2004, issue of the Journal of the American College of Cardiology.

5 Aug 2004

Blood vessel plug - amplatzer ductal occluder, performs well in trial

In the largest and longest trial yet of a device called the Amplatzer ductal occluder, a duct that shunts blood flow away from the lungs during fetal development but sometimes fails to close after birth, was successfully closed in almost all patients, according to a new study in the Aug. 4, 2004, issue of the Journal of the American College of Cardiology.

5 Aug 2004

Spitfire fighter device helps monitor aortic aneurysm

Researchers at the University of Warwick have found a way of using a test devised in the 1930s, and used to gauge the stress on the superchargers in wartime spitfire fighter planes, to model the stress that surgical procedures would put on an aortic aneurysm.

5 Aug 2004

As the saying goes “breast milk is best”

As the saying goes “breast milk is best,” and more than 85 percent of new moms who give birth at the University of Michigan Health System agree and continue to breastfeed their new bundle of joy, on average, for the first six months.

3 Aug 2004

Children with mild asthma can lose lung function

About one quarter of children in a long-term study of mild to moderate asthma suffered a significant loss of lung function over the course of four to six years.

3 Aug 2004

Pacemakers and defibrillators can be safe for use in magnetic resonance imaging machines

In animal and laboratory studies, scientists at Johns Hopkins have shown that modern, implanted heart assist devices - such as pacemakers and defibrillators - can be safe for use in magnetic resonance imaging (MRI) machines

3 Aug 2004

Half of the complications and deaths due to in-hospital DVT can be prevented with once daily dalteparin

Current research supports the use of blood-thinners to help acutely ill, hospitalized patients minimize the risk of death from a pulmonary embolism (PE) and its precursor deep vein thrombosis (DVT).

3 Aug 2004

Scripps Encinitas Program helps brain-injury patients regain living skills

Yvette, a 50-year-old stroke patient, entered the Scripps Encinitas Rehabilitation Center’s Brain Injury Day Treatment Program on March 3 in a wheelchair. On July 9, she walked out on her own with a new outlook on life.

3 Aug 2004

The NHS is effectively being privatised

The NHS is effectively being privatised – broken up into hundreds of competing companies with an independent regulator overseeing the system according to Professor Allyson Pollock of UCL's School of Public Policy.

3 Aug 2004

Third of heart failure patients face increased risk of death because they do not receive an angiotensin-converting enzyme (ACE) inhibitor

Overwhelming evidence accumulated during almost 20 years of clinical experience has established the benefits of this drug, which blocks the harmful effects of angiotensin, a substance that causes blood vessels to narrow, said the study authors.

3 Aug 2004

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

CV Therapeutics has announced that it has initiated an approval-enabling study of Ranexa, which, if successful, could support approval of Ranexa for the treatment of chronic angina in a restricted patient population.

3 Aug 2004

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension

Myogen has announced that the United States Food and Drug Administration has granted orphan drug designation to ambrisentan for the treatment of pulmonary arterial hypertension (PAH).

3 Aug 2004

Heart Disease News and Research

Latest Heart Disease News and Research

Surgeons implant a new investigational neurostimulator in a patient with medically refractory epilepsy

New guidelines for water, salt and potassium intake of Americans

24-year long asthma study is answering doctors' questions about asthma and its causes

Mefloquine, an anti-malarial drug plays a critical role in movement, vision and memory

25% of young men tested positive for a sexually transmitted infection (STI)

Current estimates have cardiovascular disease (CVD) accounting for 17 million deaths annually

Approval of cholesterol-lowering therapy Lipitor for the prevention of cardiovascular disease

Moderate exercise helps beat fatigue from prostate radiation

Atherosclerosis at menopause slowed by diet and exercise

Blood vessel plug - amplatzer ductal occluder, performs well in trial

Spitfire fighter device helps monitor aortic aneurysm

As the saying goes “breast milk is best”

Children with mild asthma can lose lung function

Pacemakers and defibrillators can be safe for use in magnetic resonance imaging machines

Half of the complications and deaths due to in-hospital DVT can be prevented with once daily dalteparin

Scripps Encinitas Program helps brain-injury patients regain living skills

The NHS is effectively being privatised

Third of heart failure patients face increased risk of death because they do not receive an angiotensin-converting enzyme (ACE) inhibitor

CV Therapeutics initiates approval-enabling trial of drug to treat chronic angina

FDA has granted orphan drug designation to Myogen's ambrisentan, for the treatment of pulmonary arterial hypertension

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Heart Disease News and Research

Latest Heart Disease News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in